(Q34308948)

1 August 2017

1 reference

title

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences (English)

1 reference

1 August 2017

1 reference

Bogdanos DP

1

1 reference

1 August 2017

Choudhuri K

series ordinal

2

1 reference

1 August 2017

Vergani D

series ordinal

3

1 reference

1 August 2017

language of work or name

1 reference

1 August 2001

1 reference

1 August 2017

1 reference

1 August 2017

21

1 reference

1 August 2017

4

1 reference

1 August 2017

225-232

1 reference

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

1 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Virus, liver and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

LKM antibody: getting in some target practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Positional cloning of the APECED gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Bacteriuria and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Risk factors for primary biliary cirrhosis in a cohort of patients from the united states

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

The structure of ClpP at 2.3 A resolution suggests a model for ATP-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Side effects of alpha interferon in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Molecular mimicry in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

Type 2 autoimmune hepatitis and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

Type II autoimmune hepatitis. What is the role of the hepatitis C virus?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

A possible novel src-related tyrosine kinase in cancer cells of LEC rats that develop hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0676.2001.021004225.X

7 January 2021

10.1034/J.1600-0676.2001.021004225.X

Identifiers

DOI

1 reference

1 August 2017

1 reference